Scholars Central

Review articlePublished 2013

STEM CELLS: A CASE STUDY OF NOVEL INNOVATIONS TO ACCELERATE DRUG DISCOVERY

Authors: Brandon M. Law

Journal of Pharmaceutical and Scientific Innovation

Volume 12 · Issue 1 · Pages 1–0

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Pharmaceutical companies are facing increasing costs in their drug discovery programs. Poor mouse models and the lack of supply of patient-specific human tissue have inhibited progress in drug discovery for many diseases. However, recent innovations in pluripotent stem cell technology may be able to alleviate this bottleneck and thereby offer a major paradigm shift in the way pharmaceutical companies conduct drug discovery. This present review attempts to overview the general understanding of induced pluripotent stem cell biology and explores its possible application in drug discovery for Cystic Fibrosis.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Pharmaceutical and Scientific Innovation.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Pharmaceutical and Scientific Innovation
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Brandon M. Law”